BioELife Corp.
LITH
$0.0001
$0.000.00%
OTC PK
| 09/30/2019 | 06/30/2019 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -9.68% | -16.54% | |||
| Depreciation & Amortization | 300.00% | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.02% | -16.09% | |||
| Operating Income | 5.02% | 16.09% | |||
| Income Before Tax | 54.43% | -232.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 54.43% | -232.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 54.43% | -232.25% | |||
| EBIT | 5.02% | 16.09% | |||
| EBITDA | 9.68% | 16.54% | |||
| EPS Basic | 74.31% | -229.74% | |||
| Normalized Basic EPS | 45.83% | 66.67% | |||
| EPS Diluted | 74.31% | -229.74% | |||
| Normalized Diluted EPS | 45.83% | 66.67% | |||
| Average Basic Shares Outstanding | 78.21% | 1.74% | |||
| Average Diluted Shares Outstanding | 78.21% | 1.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||